Catalyst Wire Dossier Catalyst Wire Dossier

ORIAHNN

ELAGOLIX AND ESTRADIOL AND NORETHISTERONE · AbbVie Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ORIAHNN, covering 2020-05-29 to 2025-12-17. Get the full timeline:

Most recent: FDA Approved: ORIAHNN — Supplemental Application (AbbVie Inc.)

See pricing